Scholl H, Schmidt K, Weber B
J Chromatogr. 1987 May 15;416(2):321-30. doi: 10.1016/0378-4347(87)80515-7.
An analytical method for the detection and quantification of ciprofloxacin and its known metabolites M1, M2, M3 and M4 in urine, serum/plasma, bile, faeces and tissue is described. For the liquid matrices the only sample preparation that is required is dilution. The assay consists of reversed-phase high-performance liquid chromatography and fluorescence detection. For the metabolites M2, M3 and M4 an additional post-column derivatization by successive thermolysis and photolysis is needed. A suitable simple post-column reactor has been constructed. Detection limits for all compounds are between 0.2 and 2.2 ng/ml (absolute detection limits 2-22 pg). Compared with fluorescence detection alone, the derivatization increases the selectivity of detection significantly. The linearity, precision and accuracy of the method were determined.
描述了一种用于检测和定量尿液、血清/血浆、胆汁、粪便和组织中环丙沙星及其已知代谢物M1、M2、M3和M4的分析方法。对于液体基质,所需的唯一样品制备步骤是稀释。该测定法包括反相高效液相色谱法和荧光检测。对于代谢物M2、M3和M4,需要通过连续热解和光解进行额外的柱后衍生化。构建了一个合适的简单柱后反应器。所有化合物的检测限在0.2至2.2 ng/ml之间(绝对检测限为2-22 pg)。与单独的荧光检测相比,衍生化显著提高了检测的选择性。测定了该方法的线性、精密度和准确度。